coated Tablets
Sponsors
International Bio Service, Abbott Healthcare Products B.V., International Bio Service Co., Ltd., Bio-innova and Synchron.Co.,Ltd
Conditions
Bioequivalence Study,Bioequivalence study
Bioequivalence study
EntacaponeBioequivalence study
Bioequivalence study
RivaroxabanHealthy Thai VolunteersHealthy volunteersHealthy volunteers
Healthy volunteers
Bioequivalence
Etoricoxib
Pharmacokinetic study
Phase 1
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Levocetirizine Dihydrochloride 5 mg Film-coated Tablets and Reference Product Xyzal® in Healthy Thai Volunteers under Fasting Condition
Active, not recruitingTCTR20171010001
Start: 2017-10-04Target: 26Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of 200 mg Voriconazole Film-coated Tablets Preparations in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180104003
Start: 2018-02-01Target: 48Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Fexofenadine Hydrochloride 180 mg Film-coated Tablets and Reference Product (Telfast® 180mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180517002
Start: 2018-09-01Target: 42Updated: 2026-03-30
A Randomized, Single-Dose, Two-way Crossover, Open-label Study to Evaluate the Pharmacokinetics of Etoricoxib Tablet 120 mg and Arcoxia(R) 120 mg in Healthy Thai Subjects under Fasting Conditions
Active, not recruitingTCTR20190428001
Start: 2019-07-05Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Olmesartan Medoxomil 40 mg Film-coated Tablets and Reference Product (OLMETEC) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20200916004
Start: 2020-11-16Target: 28Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Solifenacin 10 mg Film-coated Tablets and Reference Product (Vesicare® 10 mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20201109002
Start: 2021-02-01Target: 32Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban 20 mg film-coated tablets relative to XARELTO 20 mg film-coated tablets in healthy Thai volunteers under fed condition
Active, not recruitingTCTR20201122001
Start: 2021-06-08Target: 24Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban 10 mg film-coated tablets relative to XARELTO 10 mg film-coated tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20201123001
Start: 2021-06-08Target: 30Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, fully replicate crossover design with four-period, two-treatment and two-sequence of Entacapone 200 mg film-coated tablets relative to COMTAN 200 mg film-coated tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20201207005
Start: 2021-04-22Target: 40Updated: 2026-03-30